On the other hand, there is a controversy over the use of insulin for patients with diabetes at risk of cancer, as it mediates not only the glucose-lowering but the cell proliferative effect of insulin receptor signaling, thus possibly leading to the outgrowth of latent tumor buds. This evidence concerns the gene INS and cancer.